On BH3 mimetics and Ca2+ signaling

Ferdek, Pawel and Jakubowska, Monika 2017. On BH3 mimetics and Ca2+ signaling. Drug Development Research 78 (6) , pp. 313-318. 10.1002/ddr.21405

Preview

PDF - Published Version Available under License Creative Commons Attribution. Download (229kB) | Preview

Abstract

BH3 mimetics are anticancer agents that reproduce the spatial arrangement of the BH3 domain of Bcl-2 family proteins. Just like the BH3-only proteins, these compounds bind to the hydrophobic cleft of the pro-survival Bcl-2 members such as Bcl-2 or Bcl-xL, and disrupt their heterodimerization with pro-apoptotic Bax or Bak, sensitizing cells to chemotherapy. In recent years, it has become clear that Bcl-2 family proteins are engaged in regulation of intracellular Ca2+ homeostasis, including Ca2+ release from the intracellular stores as well as Ca2+ fluxes across the plasma membrane. Given that BH3 mimetics shift the balance between the prosurvival and proapoptotic Bcl-2 members, they might indirectly exert effects on intracellular Ca2+ signals. Indeed, it has been reported that some BH3 mimetics release Ca2+ from the intracellular stores causing Ca2+ overload in the cytosol. Therefore, the effects of any new BH3 mimetics on cellular Ca2+ homeostasis should be tested before these compounds progress

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Biosciences
Publisher:	Wiley
ISSN:	0272-4391
Funders:	Medical Research Council
Date of First Compliant Deposit:	17 August 2017
Date of Acceptance:	31 July 2017
Last Modified:	12 May 2023 11:11
URI:	https://orca.cardiff.ac.uk/id/eprint/103745

Citation Data

Cited 4 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item